CDK 4/6 inhibitors combined with radiotherapy: A review of literature

Bosacki, C; Bouleftour, W; Sotton, S; Vallard, A; Daguenet, E; Ouaz, H; Cojoracu, I; Moslemi, D; Molekzadehmoghani, M; Magne, N

Magne, N (corresponding author), Lucien Neuwirth Canc Inst, Dept Radiat Oncol, 108 Bis Ave Albert Raimond,BP60008, F-42271 St Priest En Jarez, France.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021; 26 (): 79

Abstract

Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) namely palbociclib, ribociclib and abemaciclib were granted approval by the European Medicines Ag......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索